Pamidronate and metastatic breast cancer
Rubiales, A.S.; Centeno, C.
New England Journal of Medicine 336(22): 1609
1997
ISSN/ISBN: 0028-4793 PMID: 9173262 Document Number: 473807
Document emailed within 1 workday
Related Documents
Theriault, R. 1996: Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients British Journal of Clinical Practice. Suppl 87: 8Chagpar, A.B. 2007: Insights into the management of locally advanced, inflammatory, and metastatic breast cancer: highlights from the 2007 Louisville Breast Cancer Update Journal of the Kentucky Medical Association 105(11): 559-560
Gebauer, G.; Jäger, W.; Lang, N. 1998: mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells Anticancer Research 18(2a): 1191-1195
Rosen, L.S.; Gordon, D.; Kaminski, M.; Howell, A.; Belch, A.; Mackey, J.; Apffelstaedt, J.; Hussein, M.; Coleman, R.E.; Reitsma, D.J.; Seaman, J.J.; Chen, B.L.; Ambros, Y. 2001: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial Cancer Journal 7(5): 377-387
Durai, R.; Ruhomauly, S.N.; Wilson, E.; Hoque, H. 2009: Metastatic renal cell carcinoma presenting as a breast lump in a treated breast cancer patient Singapore Medical Journal 50(8): e277-e279
Kraj, M.; Pogłód, R.; Pawlikowski, J.; Maj, S.; Nasiłowska, B. 2000: Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. the results of the first 12 months of pamidronate therapy Acta Poloniae Pharmaceutica 57 Suppl: 113-116
Yokdang, N.; Buxton, N.D.; Buxton, I.L.O. 2009: Measurement of human breast tumor cell-secreted shNDPK-B in a murine breast cancer model suggests its role in metastatic progression Proceedings of the Western Pharmacology Society 52: 88-91
Matsutani, S.; Tanaka, H.; Sakurai, K.; Lee, T.; Toyokawa, T.; Kubo, N.; Muguruma, K.; Kimura, K.; Nagahara, H.; Noda, E.; Amano, R.; Maeda, K.; Sawada, T.; Ohira, M.; Hirakawa, K. 2013: A case of metastatic gastric cancer from breast cancer treated with proximal gastrectomy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2210-2213
Incorvaia, L.; Badalamenti, G.; Rini, G.; Arcara, C.; Fricano, S.; Sferrazza, C.; Di Trapani, D.; Gebbia, N.; Leto, G. 2007: MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone Anticancer Research 27(3b): 1519-1525
Aapro, M.S. 1997: Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer Oncology 11(8 Suppl 8: 46-49
Carpenter, J.T.; Raney, M.; Logan, T. 1986: Phase Ii evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(5): 679-680
Nicholson, B.; Paul, D.; Shyr, Y.; Garrett, M.; Hande, K.R.; Johnson, D.H. 1997: Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase Ii trial Seminars in Oncology 24(4 Suppl 11: S11
Mousavi, M. 1980: Metastatic cancer in the breast Journal of the Medical Society of New Jersey 77(6): 435-437
O'Brien, P.H. 1978: Strategies in metastatic breast cancer Journal of the South Carolina Medical Association 74(11): 484-486
Ashton, P.R.; Hollingsworth, A.S.; Johnston, W.W. 1975: The cytopathology of metastatic breast cancer Acta Cytologica 19(1): 1-6
Takehara, K.; Koga, S.; Nishikido, M.; Kanetake, H.; Hayashi, T.; Hara, S.; Ayabe, H.; Saito, Y. 1999: Breast cancer metastatic to the kidney Anticancer Research 19(6c): 5571-5573
Gockerman, J.P.; Spremulli, E.N.; Raney, M.; Logan, T. 1986: Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial Cancer Treatment Reports 70(10): 1199-1203
Manni, A. 1987: Tamoxifen therapy of metastatic breast cancer Journal of Laboratory and Clinical Medicine 109(3): 290-299
Gehl, J.; Boesgaard, M.; Paaske, T.; Jensen, B.V.; Dombernowsky, P. 1996: Paclitaxel and doxorubicin in metastatic breast cancer Seminars in Oncology 23(6 Suppl 15: 35-38
Hernández, E.; De La Mota-Peynado, A.; Dharmawardhane, S.; Vlaar, C.P. 2010: Novel inhibitors of Rac1 in metastatic breast cancer Puerto Rico Health Sciences Journal 29(4): 348-356